Suchergebnisse - "Mlynska, Agata"

PubPharm (18)

1

Defining Melanoma Immune Biomarkers-Desert, Excluded, and Inflamed Subtypes-Using a Gene Expression Classifier Reflecting Intratumoral Immune Response and Stromal Patterns

enthalten in: Biomolecules | 2024

von Mlynska, A. | Gibavičienė, J. | Kutanovaitė, O. | +13

2

Immunomodulatory properties of bacteriophage derived dsRNA of different size and their use as anticancer vaccine adjuvants

enthalten in: Vaccine | 2024

von Dobrovolskienė, N. | Balevičius, R. | Mlynska, A. | +6

3

Correction to : Functional antigen processing and presentation mechanism as a prerequisite factor of response to treatment with dendritic cell vaccines and anti-PD-1 in preclinical murine LLC1 and GL261 tumor models

enthalten in: Cancer immunology, immunotherapy : CII | 2022

von Žilionytė, K. | Bagdzevičiūtė, U. | Mlynska, A. | +5

ErratumFor: Cancer Immunol Immunother. 2022 Nov;71(11):2691-2700. - PMID 35364740

4

Functional antigen processing and presentation mechanism as a prerequisite factor of response to treatment with dendritic cell vaccines and anti-PD-1 in preclinical murine LLC1 and GL261 tumor models

enthalten in: Cancer immunology, immunotherapy : CII | 2022

von Žilionytė, K. | Bagdzevičiūtė, U. | Mlynska, A. | +5

ErratumIn: Cancer Immunol Immunother. 2022 Apr 25;:. - PMID 35467108

5

Correction to: Functional antigen processing and presentation mechanism as a prerequisite factor of response to treatment with dendritic cell vaccines and anti-PD-1 in preclinical murine LLC1 and GL261 tumor models

enthalten in: Cancer immunology immunotherapy | 2022

von Žilionytė, K. | Bagdzevičiūtė, U. | Mlynska, A. | +5

6

Correction to: Functional antigen processing and presentation mechanism as a prerequisite factor of response to treatment with dendritic cell vaccines and anti-PD-1 in preclinical murine LLC1 and GL261 tumor models

enthalten in: Cancer immunology immunotherapy | 2022

von Žilionytė, K. | Bagdzevičiūtė, U. | Mlynska, A. | +5

7

Functional antigen processing and presentation mechanism as a prerequisite factor of response to treatment with dendritic cell vaccines and anti-PD-1 in preclinical murine LLC1 and GL261 tumor models

enthalten in: Cancer immunology immunotherapy | 2022

von Žilionytė, K. | Bagdzevičiūtė, U. | Mlynska, A. | +5

8

Functional antigen processing and presentation mechanism as a prerequisite factor of response to treatment with dendritic cell vaccines and anti-PD-1 in preclinical murine LLC1 and GL261 tumor models

enthalten in: Cancer immunology immunotherapy | 2022

von Žilionytė, K. | Bagdzevičiūtė, U. | Mlynska, A. | +5

9

Immunophenotype Rearrangement in Response to Tumor Excision May Be Related to the Risk of Biochemical Recurrence in Prostate Cancer Patients

enthalten in: Journal of clinical medicine | 2021

von Bosas, P. | Zaleskis, G. | Dabkevičiene, D. | +7

10

A gene signature for immune subtyping of desert, excluded, and inflamed ovarian tumors

enthalten in: American journal of reproductive immunology (New York, N.Y. : 1989) | 2020

von Mlynska, A. | Vaišnorė, R. | Rafanavičius, V. | +11